Cambridge Heart Inc. issues a warrant call for $962,000 worth of warrants it issued last year as part of a Series D financing round.

Cambridge Heart Inc. (OTC:CAMH) issued a call for nearly $1 million worth of long-term warrants it issued last year as part of a Series D funding round.
The Tewksbury, Mass.-based heart test maker said it would net $754,000 if all holders of the warrants for 6,775,611 shares exercise them at their 14.2 cent share price. Cambridge Heart already pulled in $208,000 from the exercise of some of the warrants.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
Volcano posts positive preliminary findings demonstrating the benefit of a hybrid iFR/FFR approach to...
Medical device giant Medtronic says its European CE Mark is the 1st ever regulatory approval for...
Johnson & Johnson subsidiary Biosense Webster enrolls its 1st patient in the reMARQable clinical...
Four health systems create a collaborative group as part of the Premier network